Willow Biosciences Inc. (CANSF)
USD 0.04
(-4.55%)
USD 0.04
(-4.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.17 Million | 821 Thousand | 133 Thousand | 10 Thousand | 4584.00 | 16.91 Thousand |
| Cost of Revenue | 1.83 Million | 7.47 Million | 11.53 Million | - | - | - |
| Gross Profit | -659 Thousand | -6.65 Million | -11.4 Million | 10 Thousand | 4584.00 | 16.91 Thousand |
| Operating Expenses | 7.55 Million | 19.22 Million | 23.3 Million | 16.85 Million | 13.08 Million | 1.66 Million |
| Selling, General and Administrative Expenses | 6.01 Million | 9.1 Million | 8.6 Million | 6.41 Million | 8.24 Million | 1.54 Million |
| Research and Development Expenses | 6.8 Million | 7.47 Million | 11.51 Million | 7.25 Million | 2.67 Million | 387.47 Thousand |
| Other Expenses | 1.53 Million | - | -22 Thousand | - | - | - |
| Cost and Expenses | 14.35 Million | 19.22 Million | 23.3 Million | 16.85 Million | 13.08 Million | 1.66 Million |
| Operating Income | -13.18 Million | -18.39 Million | -23.33 Million | -23.06 Million | -46.14 Million | -1.64 Million |
| Interest Expense | 142 Thousand | 26 Thousand | 27 Thousand | 40 Thousand | 48.13 Thousand | - |
| Income Tax Expense | -5000.00 | 53 Thousand | 27 Thousand | 40 Thousand | -1.58 Million | -114.75 Thousand |
| Earnings before Tax | -13.03 Million | -14.76 Million | -6.14 Million | -33.94 Million | -46.14 Million | -1.64 Million |
| Net Income | -13.02 Million | -14.81 Million | -6.14 Million | -33.94 Million | -44.56 Million | -1.64 Million |
| Earnings Per Share Basic | -0.10 | -0.12 | -0.05 | -0.41 | -0.62 | -0.75 |
| Earnings Per Share Diluted | -0.10 | -0.12 | -0.05 | -0.41 | -0.62 | -0.75 |
| Weighted Average Shares Outstanding | 124.24 Million | 123.66 Million | 119.98 Million | 81.99 Million | 72.07 Million | 2.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 124.24 Million | 123.66 Million | 119.98 Million | 81.99 Million | 72.07 Million | 2.19 Million |
| Gross Margin | -0.56 | -8.10 | -85.71 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -9.92 | -18.82 | -147.13 | -1350.90 | -2355.08 | -94.49 |
| Profit Margin | -11.12 | -18.04 | -46.17 | -3394.60 | -9722.21 | -97.24 |
| EBITDA | -11.62 Million | -15.45 Million | -2.92 Million | -30.72 Million | -43.93 Million | -1.59 Million |
| Earnings Before Tax Margin | -11.25 | -22.40 | -175.41 | -2306.10 | -10.06 Thousand | -97.24 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.02 Million | 51 Thousand | 1.17 Million | 89 Thousand | 674 Thousand | 135 Thousand |
| Cost of Revenue | 353 Thousand | 352 Thousand | 1.83 Million | 377 Thousand | 558 Thousand | 1.93 Million |
| Gross Profit | 673 Thousand | -301 Thousand | -659 Thousand | -288 Thousand | 116 Thousand | -1.79 Million |
| Operating Expenses | 2.11 Million | 2.15 Million | 12.79 Million | 2.44 Million | 2.91 Million | 3.78 Million |
| Selling, General and Administrative Expenses | 889 Thousand | 1.04 Million | - | 1.26 Million | 758 Thousand | 1.4 Million |
| Research and Development Expenses | 1.23 Million | 1.11 Million | - | 1.17 Million | 1.59 Million | 1.93 Million |
| Other Expenses | -873 Thousand | - | - | - | - | - |
| Cost and Expenses | 2.47 Million | 2.5 Million | 14.63 Million | 2.82 Million | 2.91 Million | 3.78 Million |
| Operating Income | -1.44 Million | -2.45 Million | -13.45 Million | -2.73 Million | -2.23 Million | -3.64 Million |
| Interest Expense | 47 Thousand | 33 Thousand | 142 Thousand | - | - | - |
| Income Tax Expense | 190 Thousand | 2000.00 | -5000.00 | -25 Thousand | -8000.00 | 20 Thousand |
| Earnings before Tax | -1.49 Million | -2.35 Million | -13.03 Million | -2.44 Million | -2.23 Million | -3.58 Million |
| Net Income | -1.68 Million | -2.35 Million | -13.02 Million | -2.42 Million | -2.23 Million | -3.6 Million |
| Earnings Per Share Basic | -0.01 | -0.02 | - | -0.02 | -0.02 | -0.03 |
| Earnings Per Share Diluted | -0.01 | -0.02 | - | -0.02 | -0.02 | -0.03 |
| Weighted Average Shares Outstanding | 127.25 Million | 125.44 Million | 124.24 Million | 124.43 Million | 124.23 Million | 124.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 127.25 Million | 125.44 Million | 124.24 Million | 124.43 Million | 124.23 Million | 124.17 Million |
| Gross Margin | 0.66 | -5.90 | -0.56 | -3.24 | 0.17 | -13.30 |
| EBIT Margin | -1.07 | -41.25 | - | -26.49 | -2.50 | -23.73 |
| Profit Margin | -1.64 | -46.24 | -11.12 | -27.24 | -3.31 | -26.70 |
| EBITDA | -1.09 Million | -2.1 Million | - | -2.35 Million | -1.68 Million | -3.2 Million |
| Earnings Before Tax Margin | -1.41 | -48.16 | -11.48 | -30.73 | -3.32 | -27.01 |
293780
950160
129260
1313
CPA
RSE